Skip to main content
Top

20-04-2024 | Gaucher Disease | Hepatobiliary

Multiparametric magnetic resonance imaging of the liver and spleen in Gaucher disease

Authors: Daniella Braz Parente, Fernanda Chagas Monteiro de Melo Malta, Renata de Souza Cravo, Ronir Raggio Luiz, Vivian Rotman, Renata Mello Perez, Rosana Souza Rodrigues

Published in: Abdominal Radiology

Login to get access

Abstract

Purpose

To assess liver and spleen characteristics of a population with Gaucher disease (GD) using multiparametric MRI and MR elastography (MRE) for evaluation of diffuse liver and spleen disease, which includes liver fat fraction, liver and spleen volume and iron deposition, and liver and spleen stiffness correlated with DS3 Severity Scoring System for Gaucher disease (GD-DS3).

Methods

We prospectively evaluated 41 patients with type 1 Gaucher disease using a 3.0 T MRI and MRE between January 2019 and February 2020. Clinical, laboratory, and imaging data was collected. Mann–Whitney, Kruskal–Wallis, and Spearman’s correlation were applied to evaluate liver and spleen MRI and MRE, clinical and laboratory variables, and GD-DS3. ERT and SRT treatment groups were compared.

Results

Hepatomegaly was seen in 15% and splenomegaly in 42% of the population. Moderate and strong and correlations were found between liver and spleen iron overload (rho = 0.537; p = 0.002); between liver and spleen volume (rho = 0.692, p < 0.001) and between liver and spleen stiffness (rho = 0.453, p = 0.006). Moderate correlations were found between liver stiffness and GD-DS3 (rho = 0.559; p < 0.001) and between splenic volume and GD-DS3 (rho = 0.524; p = 0.001).

Conclusion

The prevalence of hepatosplenomegaly, liver fibrosis, and liver iron overload in treated patients with GD is low, which may be related to the beneficial effect of treatment. Liver MRE and splenic volume correlate with severity score and may be biomarkers of disease severity.

Graphical abstract

Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Dandana A, Ben Khelifa S, Chahed H, Miled A, Ferchichi S. Gaucher Disease: Clinical, Biological and Therapeutic Aspects. Pathobiology 2016; 83:13-23CrossRefPubMed Dandana A, Ben Khelifa S, Chahed H, Miled A, Ferchichi S. Gaucher Disease: Clinical, Biological and Therapeutic Aspects. Pathobiology 2016; 83:13-23CrossRefPubMed
3.
4.
go back to reference Andrade-Campos MM, de Frutos LL, Cebolla JJ, et al. Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher disease. Orphanet J Rare Dis 2020; 15:256CrossRefPubMedPubMedCentral Andrade-Campos MM, de Frutos LL, Cebolla JJ, et al. Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher disease. Orphanet J Rare Dis 2020; 15:256CrossRefPubMedPubMedCentral
5.
go back to reference Pandey MK, Burrow TA, Rani R, et al. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease. Nature 2017; 543:108-112CrossRefPubMed Pandey MK, Burrow TA, Rani R, et al. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease. Nature 2017; 543:108-112CrossRefPubMed
6.
go back to reference Pandey MK, Grabowski GA, Kohl J. An unexpected player in Gaucher disease: The multiple roles of complement in disease development. Semin Immunol 2018; 37:30-42CrossRefPubMed Pandey MK, Grabowski GA, Kohl J. An unexpected player in Gaucher disease: The multiple roles of complement in disease development. Semin Immunol 2018; 37:30-42CrossRefPubMed
7.
go back to reference Kaluzna M, Trzeciak I, Ziemnicka K, Machaczka M, Ruchala M. Endocrine and metabolic disorders in patients with Gaucher disease type 1: a review. Orphanet J Rare Dis 2019; 14:275CrossRefPubMedPubMedCentral Kaluzna M, Trzeciak I, Ziemnicka K, Machaczka M, Ruchala M. Endocrine and metabolic disorders in patients with Gaucher disease type 1: a review. Orphanet J Rare Dis 2019; 14:275CrossRefPubMedPubMedCentral
8.
go back to reference Nascimbeni F, Dalla Salda A, Carubbi F. Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease. Blood Cells Mol Dis 2018; 68:74-80CrossRefPubMed Nascimbeni F, Dalla Salda A, Carubbi F. Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease. Blood Cells Mol Dis 2018; 68:74-80CrossRefPubMed
9.
go back to reference Adar T, Ilan Y, Elstein D, Zimran A. Liver involvement in Gaucher disease - Review and clinical approach. Blood Cells Mol Dis 2018; 68:66-73CrossRefPubMed Adar T, Ilan Y, Elstein D, Zimran A. Liver involvement in Gaucher disease - Review and clinical approach. Blood Cells Mol Dis 2018; 68:66-73CrossRefPubMed
10.
go back to reference Serai SD, Naidu AP, Andrew Burrow T, Prada CE, Xanthakos S, Towbin AJ. Correlating liver stiffness with disease severity scoring system (DS3) values in Gaucher disease type 1 (GD1) patients. Mol Genet Metab 2018; 123:357-363CrossRefPubMed Serai SD, Naidu AP, Andrew Burrow T, Prada CE, Xanthakos S, Towbin AJ. Correlating liver stiffness with disease severity scoring system (DS3) values in Gaucher disease type 1 (GD1) patients. Mol Genet Metab 2018; 123:357-363CrossRefPubMed
11.
go back to reference Starosta RT, Vairo FPE, Dornelles AD, et al. Liver involvement in patients with Gaucher disease types I and III. Mol Genet Metab Rep 2020; 22:100564PubMedPubMedCentral Starosta RT, Vairo FPE, Dornelles AD, et al. Liver involvement in patients with Gaucher disease types I and III. Mol Genet Metab Rep 2020; 22:100564PubMedPubMedCentral
12.
go back to reference Regenboog M, Bohte AE, Somers I, van Delden OM, Maas M, Hollak CE. Imaging characteristics of focal splenic and hepatic lesions in type 1 Gaucher disease. Blood Cells Mol Dis 2016; 60:49-57CrossRefPubMed Regenboog M, Bohte AE, Somers I, van Delden OM, Maas M, Hollak CE. Imaging characteristics of focal splenic and hepatic lesions in type 1 Gaucher disease. Blood Cells Mol Dis 2016; 60:49-57CrossRefPubMed
13.
go back to reference Degnan AJ, Ho-Fung VM, Ahrens-Nicklas RC, et al. Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement. Insights Imaging 2019; 10:70CrossRefPubMedPubMedCentral Degnan AJ, Ho-Fung VM, Ahrens-Nicklas RC, et al. Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement. Insights Imaging 2019; 10:70CrossRefPubMedPubMedCentral
14.
go back to reference Ma X, Holalkere NS, Kambadakone RA, Mino-Kenudson M, Hahn PF, Sahani DV. Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics 2009; 29:1253-1277CrossRefPubMed Ma X, Holalkere NS, Kambadakone RA, Mino-Kenudson M, Hahn PF, Sahani DV. Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics 2009; 29:1253-1277CrossRefPubMed
15.
go back to reference Starekova J, Hernando D, Pickhardt PJ, Reeder SB. Quantification of Liver Fat Content with CT and MRI: State of the Art. Radiology 2021; 301:250-262CrossRefPubMed Starekova J, Hernando D, Pickhardt PJ, Reeder SB. Quantification of Liver Fat Content with CT and MRI: State of the Art. Radiology 2021; 301:250-262CrossRefPubMed
16.
go back to reference Franca M, Alberich-Bayarri A, Marti-Bonmati L, et al. Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI. Abdom Radiol (NY) 2017; 42:1434-1443CrossRefPubMed Franca M, Alberich-Bayarri A, Marti-Bonmati L, et al. Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI. Abdom Radiol (NY) 2017; 42:1434-1443CrossRefPubMed
17.
go back to reference Garteiser P, Doblas S, Van Beers BE. Magnetic resonance elastography of liver and spleen: Methods and applications. NMR Biomed 2018; 31:e3891CrossRefPubMed Garteiser P, Doblas S, Van Beers BE. Magnetic resonance elastography of liver and spleen: Methods and applications. NMR Biomed 2018; 31:e3891CrossRefPubMed
18.
go back to reference Idilman IS, Li J, Yin M, Venkatesh SK. MR elastography of liver: current status and future perspectives. Abdom Radiol (NY) 2020; 45:3444-3462CrossRefPubMed Idilman IS, Li J, Yin M, Venkatesh SK. MR elastography of liver: current status and future perspectives. Abdom Radiol (NY) 2020; 45:3444-3462CrossRefPubMed
19.
go back to reference Bohte AE, van Dussen L, Akkerman EM, et al. Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage. PLoS One 2013; 8:e57507CrossRefPubMedPubMedCentral Bohte AE, van Dussen L, Akkerman EM, et al. Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage. PLoS One 2013; 8:e57507CrossRefPubMedPubMedCentral
21.
go back to reference Vauthey JN, Abdalla EK, Doherty DA, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 2002; 8:233-240CrossRefPubMed Vauthey JN, Abdalla EK, Doherty DA, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 2002; 8:233-240CrossRefPubMed
22.
go back to reference Kim DW, Ha J, Lee SS, et al. Population-based and Personalized Reference Intervals for Liver and Spleen Volumes in Healthy Individuals and Those with Viral Hepatitis. Radiology 2021; 301:339-347CrossRefPubMed Kim DW, Ha J, Lee SS, et al. Population-based and Personalized Reference Intervals for Liver and Spleen Volumes in Healthy Individuals and Those with Viral Hepatitis. Radiology 2021; 301:339-347CrossRefPubMed
23.
go back to reference d'Assignies G, Paisant A, Bardou-Jacquet E, et al. Non-invasive measurement of liver iron concentration using 3-Tesla magnetic resonance imaging: validation against biopsy. Eur Radiol 2018; 28:2022-2030CrossRefPubMed d'Assignies G, Paisant A, Bardou-Jacquet E, et al. Non-invasive measurement of liver iron concentration using 3-Tesla magnetic resonance imaging: validation against biopsy. Eur Radiol 2018; 28:2022-2030CrossRefPubMed
24.
go back to reference Henninger B, Alustiza J, Garbowski M, Gandon Y. Practical guide to quantification of hepatic iron with MRI. Eur Radiol 2020; 30:383-393CrossRefPubMed Henninger B, Alustiza J, Garbowski M, Gandon Y. Practical guide to quantification of hepatic iron with MRI. Eur Radiol 2020; 30:383-393CrossRefPubMed
25.
go back to reference Alustiza JM, Artetxe J, Castiella A, et al. MR quantification of hepatic iron concentration. Radiology 2004; 230:479-484CrossRefPubMed Alustiza JM, Artetxe J, Castiella A, et al. MR quantification of hepatic iron concentration. Radiology 2004; 230:479-484CrossRefPubMed
26.
go back to reference Srinivasa Babu A, Wells ML, Teytelboym OM, et al. Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions. Radiographics 2016; 36:1987-2006CrossRefPubMed Srinivasa Babu A, Wells ML, Teytelboym OM, et al. Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions. Radiographics 2016; 36:1987-2006CrossRefPubMed
27.
go back to reference Weinreb NJ, Finegold DN, Feingold E, et al. Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3). Orphanet J Rare Dis 2015; 10:64CrossRefPubMedPubMedCentral Weinreb NJ, Finegold DN, Feingold E, et al. Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3). Orphanet J Rare Dis 2015; 10:64CrossRefPubMedPubMedCentral
28.
go back to reference Webb M, Zimran A, Dinur T, et al. Are transient and shear wave elastography useful tools in Gaucher disease? Blood Cells Mol Dis 2018; 68:143-147CrossRefPubMed Webb M, Zimran A, Dinur T, et al. Are transient and shear wave elastography useful tools in Gaucher disease? Blood Cells Mol Dis 2018; 68:143-147CrossRefPubMed
29.
go back to reference Patlas M, Hadas-Halpern I, Abrahamov A, Elstein D, Zimran A. Spectrum of abdominal sonographic findings in 103 pediatric patients with Gaucher disease. Eur Radiol 2002; 12:397-400CrossRefPubMed Patlas M, Hadas-Halpern I, Abrahamov A, Elstein D, Zimran A. Spectrum of abdominal sonographic findings in 103 pediatric patients with Gaucher disease. Eur Radiol 2002; 12:397-400CrossRefPubMed
30.
go back to reference Hill SC, Damaska BM, Ling A, et al. Gaucher disease: abdominal MR imaging findings in 46 patients. Radiology 1992; 184:561-566CrossRefPubMed Hill SC, Damaska BM, Ling A, et al. Gaucher disease: abdominal MR imaging findings in 46 patients. Radiology 1992; 184:561-566CrossRefPubMed
31.
go back to reference James SP, Stromeyer FW, Chang C, Barranger JA. LIver abnormalities in patients with Gaucher's disease. Gastroenterology 1981; 80:126-133CrossRefPubMed James SP, Stromeyer FW, Chang C, Barranger JA. LIver abnormalities in patients with Gaucher's disease. Gastroenterology 1981; 80:126-133CrossRefPubMed
32.
go back to reference Hill SC, Reinig JW, Barranger JA, Fink J, Shawker TH. Gaucher disease: sonographic appearance of the spleen. Radiology 1986; 160:631-634CrossRefPubMed Hill SC, Reinig JW, Barranger JA, Fink J, Shawker TH. Gaucher disease: sonographic appearance of the spleen. Radiology 1986; 160:631-634CrossRefPubMed
33.
go back to reference Neudorfer O, Hadas-Halpern I, Elstein D, Abrahamov A, Zimran A. Abdominal ultrasound findings mimicking hematological malignancies in a study of 218 Gaucher patients. Am J Hematol 1997; 55:28-34CrossRefPubMed Neudorfer O, Hadas-Halpern I, Elstein D, Abrahamov A, Zimran A. Abdominal ultrasound findings mimicking hematological malignancies in a study of 218 Gaucher patients. Am J Hematol 1997; 55:28-34CrossRefPubMed
34.
go back to reference Pastores GM, Weinreb NJ, Aerts H, et al. Therapeutic goals in the treatment of Gaucher disease. Semin Hematol 2004; 41:4-14CrossRefPubMed Pastores GM, Weinreb NJ, Aerts H, et al. Therapeutic goals in the treatment of Gaucher disease. Semin Hematol 2004; 41:4-14CrossRefPubMed
Metadata
Title
Multiparametric magnetic resonance imaging of the liver and spleen in Gaucher disease
Authors
Daniella Braz Parente
Fernanda Chagas Monteiro de Melo Malta
Renata de Souza Cravo
Ronir Raggio Luiz
Vivian Rotman
Renata Mello Perez
Rosana Souza Rodrigues
Publication date
20-04-2024
Publisher
Springer US
Published in
Abdominal Radiology
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-024-04293-w
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.